PAVmed (PAVM)
(Delayed Data from NSDQ)
$1.27 USD
-0.03 (-1.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.28 +0.01 (0.79%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for PAVmed Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 20 | 40 | 77 | 17 | 6 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5 | 4 | 5 | 2 | 0 |
Total Current Assets | 25 | 44 | 83 | 19 | 7 |
Net Property & Equipment | 2 | 2 | 2 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1 | 3 | 2 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 33 | 54 | 87 | 20 | 7 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 44 | 34 | 0 | 15 | 8 |
Accounts Payable | 2 | 3 | 3 | 3 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 7 | 4 | 4 | 2 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 54 | 41 | 8 | 20 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 57 | 43 | 8 | 20 | 12 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 3 | 3 | 2 | 3 | 2 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 238 | 216 | 198 | 88 | 48 |
Retained Earnings | -294 | -228 | -139 | -88 | -54 |
Other Equity | 30 | 21 | 18 | -2 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -24 | 11 | 79 | 0 | -5 |
Total Liabilities & Shareholder's Equity | 33 | 54 | 87 | 20 | 7 |
Total Common Equity | -27 | 8 | 77 | -3 | -7 |
Shares Outstanding | 8.00 | 6.00 | 5.80 | 4.80 | 2.50 |
Book Value Per Share | -3.38 | 1.37 | 13.28 | -0.63 | -2.78 |
Fiscal Year End for PAVmed Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 26 | 26 | 20 | 26 | 37 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 4 | 5 | 6 | 6 |
Total Current Assets | 30 | 30 | 25 | 32 | 43 |
Net Property & Equipment | 1 | 2 | 2 | 2 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1 | 1 | 1 | 2 | 2 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 39 | 37 | 33 | 42 | 54 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 44 | 46 | 44 | 45 | 43 |
Accounts Payable | 1 | 1 | 2 | 2 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 7 | 7 | 7 | 5 | 5 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 53 | 55 | 54 | 55 | 51 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 58 | 58 | 57 | 58 | 55 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 3 | 3 | 3 | 3 | 3 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 244 | 238 | 238 | 232 | 226 |
Retained Earnings | -321 | -310 | -294 | -279 | -261 |
Other Equity | 55 | 48 | 30 | 27 | 31 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -19 | -21 | -24 | -16 | -1 |
Total Liabilities & Shareholder's Equity | 39 | 37 | 33 | 42 | 54 |
Total Common Equity | -22 | -24 | -27 | -19 | -4 |
Shares Outstanding | 10.00 | 9.40 | 8.00 | 7.40 | 6.90 |
Book Value Per Share | -2.18 | -2.52 | -3.38 | -2.53 | -0.53 |